LIVN

LivaNova PLC Ordinary Shares (LIVN)

Stock · NASDAQ · Health Care

$77.61as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 10, 2026

LivaNova Shares Rise on Barclays Overweight Rating. Barclays has begun coverage of LivaNova, giving it an overweight rating and a $105 price target. The stock is currently trading near the upper end of its 52‑week range and has been on a 60% three‑year run, which some analysts see as undervalued. Technical indicators show an RSI of 45 and a support level at $78.13, with a support reject signal that may signal a short‑term consolidation.

Price chart

Open in TradingView

Active signals

Support Reject66.6%200 SMA Touch0.0%
Resistance level
$78.13
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus

LIVN Signal Track Record

How signals performed across all stocks →

What LIVN's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike36-0.5%50%
Bollinger Band Breakout24+1.8%58%
Bollinger Band Breakdown22+2.3%64%
200-Day Moving Average TouchActive now18-0.3%50%
Any 20-session window (baseline)+0.2%51%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About LIVN

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as servi…

Sector
Health Care
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Employees
3,300

Fundamentals

1-day range
$77.56$79.31
Market cap
$4.16B
P/E (trailing)
22.41
P/E (forward)
16.63
EPS (trailing)
$3.38
Dividend yield
—
Beta
0.93
Avg. volume
645.8K
52-week range
$48.82$85.76
Next earnings: November 4, 2026 · EPS estimate $1.06Before Openconfirmed

How LivaNova PLC Ordinary Shares Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$1.39BSG&A$548.81M (40%)Cost of Revenue$448.18M (32%)R&D$185.76M (13%)Other$183.65M (13%)Tax$21.64M (2%)LIVN

Source: 10-K filed Feb 25, 2026 · via SEC EDGAR / Finnhub

Gross Profit$939.87M(68%)
Operating Income$199.39M(14%)

Forecasts

11 analyst ratings

Buy 81%
Hold 19%
Sell 0%
1-year price forecast
High
$105
+35.3%
Median
$93
+19.8%
Low
$75
-3.4%

LivaNova PLC Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • LIVN
    LivaNova PLC Ordinary Shares
    $77.58
    ▼ 1.17%
    Market cap $4.16BP/E 22.41
    $48.82$85.76
  • TMDX
    TransMedics Group Inc. Common Stock
    $70.78
    ▼ 7.50%
    Market cap $2.78BP/E 17.33
    $60.11$156
  • AXGN
    Axogen Inc. Common Stock
    $34.62
    ▼ 2.83%
    Market cap $2.38BP/E —
    $15.27$52.91
  • CNMD
    CONMED Corporation Common Stock
    $46.72
    ▼ 0.89%
    Market cap $1.49BP/E 25.13
    $31.44$53.66
  • INMD
    InMode Ltd. Ordinary Shares
    $14.16
    ▼ 1.12%
    Market cap $957.98MP/E 10.66
    $12.72$16.67
  • CBLL
    CeriBell Inc. Common Stock
    $25.04
    ▼ 9.41%
    Market cap $692.45MP/E —
    $10.85$26.63
  • CV
    CapsoVision Inc. Common Stock
    $6.53
    ▲ 1.24%
    Market cap $344.75MP/E —
    $4.46$15.37

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
31.8K
Disposed
22.3K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.